Recently, the Energy Bureau of the Inner Mongolia Autonomous Region released the first batch list of independent new-type energy storage construction projects for 2026.
Recently, Valiant Pharmaceutical’s first active pharmaceutical ingredient (API), olmesartan medoxomil, successfully passed the rigorous review of the European Directorate for the Quality of Medicines and HealthCare (EDQM) and obtained the Certificate of Suitability to the European Pharmacopoeia (CEP), supported by its advanced and independently developed research and production process.
On March 12, Liao Jiasheng, Chairman of CECEP, met with Zeng Yuqun, Chairman and CEO of CATL, and his delegation at CECEP headquarters.
On February 25, Liao Jiasheng, Chairman of the Group, led members of the leadership team and senior executives on visits to various departments at the Group headquarters and subsidiaries in Beijing, extending New Year greetings and best wishes to employees.
On February 3, CECEP’s 40MW “Wind Harnessing Action for Thousands of Towns and Villages” wind power project in Xiajin County received official approval.
On February 5, CECEP convened a meeting of the Leading Group for the Yangtze River Economic Belt pollution control platform.
On January 29, the Royal Commission for Jubail and Yanbu (CRJY) officially awarded the Ras Al-Khair Industrial City seawater cooling network upgrade project in Saudi Arabia to CGC.
From January 31 to February 1, the inaugural conference and first academic meeting of the Carbon Footprint Professional Committee of the Chinese Society for Environmental Sciences was held in Nanjing, Jiangsu Province.
第  4  /  34  页  总条数: 169
Produced By CMS 网站群内容管理系统 publishdate:2026-04-16 10:20:07